
PharmaDrug (OTC: LMLLF) Announces Closing of the First Tranche of Non-Brokered Private Placement
Toronto, Ontario– May 27, 2022 – PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, […]